WUXI VACCINES
LIVE

Serial Number

97735383

Owner

Shanghai Vaccines Co., Ltd.

Attorney

Eric Lamb

Filing Date

Dec 29, 2022

Add to watchlist:

No watchlists yet
View on USPTO

WUXI VACCINES Trademark

Serial Number: 97735383 • Registration: 7369079

WUXI VACCINES is a trademark filed by Shanghai Vaccines Co., Ltd. on December 29, 2022. The trademark is classified under Class 40 (Treatment & Processing), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Shanghai Vaccines Co., Ltd. (3 trademarks)

Room 502A, 5th Floor,

Entity Type: 16

Trademark Details

Filing Date

December 29, 2022

Registration Date

April 23, 2024

Goods & Services

Custom assembling of materials for others, being custom manufacture of pharmaceuticals, chemotherapy drugs, antibiotic medicines, and vaccines by pharmaceutical compounders; Custom manufacture of medical preparations in the nature of pharmaceuticals; Customized biomanufacturing of pharmaceuticals; Custom manufacture of vaccines for preventing or treating infectious diseases, cancer and allergies or autoimmunity; Material processing being processing of medicinal plants and manufacturing of pharmaceuticals using biological organisms in the manufacturing process, all in the medicinal field; Processing of drugs, being biomanufacturing for others in the nature of custom manufacturing of pharmaceuticals; Processing of biomedical preparations, namely, biomanufacturing for others in the nature of manufacturing of pharmaceuticals and vaccines using biological organisms in the manufacturing process; Processing of vaccines, being custom manufacture of vaccines for preventing or treating infectious diseases, cancer and allergies or autoimmunity

Developing new products for others; Development of medicines; Scientific research and development; Pharmaceutical research; Research and development of new products; Consulting services in the field of development of new technology for others; Biochemical research and analysis; Biomedical research; Development of pharmaceutical preparations and pharmaceutical drugs; Research and development of pharmaceutical drugs; Custom design and development of chemical reagents for scientific or medical research use

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 23, 2024 NRCS
REGISTERED-SUPPLEMENTAL REGISTER
Apr 23, 2024 R.SR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
Mar 8, 2024 ERRR
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Mar 4, 2024 CNTA
EXAMINER'S AMENDMENT ENTERED
Mar 4, 2024 XAEC
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Mar 4, 2024 GNEN
EXAMINERS AMENDMENT E-MAILED
Mar 4, 2024 GNEA
EXAMINERS AMENDMENT -WRITTEN
Mar 4, 2024 CNEA
NOTIFICATION OF FINAL REFUSAL EMAILED
Dec 4, 2023 GNFN
FINAL REFUSAL E-MAILED
Dec 4, 2023 GNFR
FINAL REFUSAL WRITTEN
Dec 4, 2023 CNFR
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 30, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 30, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Nov 30, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Sep 27, 2023 GNRN
NON-FINAL ACTION E-MAILED
Sep 27, 2023 GNRT
NON-FINAL ACTION WRITTEN
Sep 27, 2023 CNRT
ASSIGNED TO EXAMINER
Sep 26, 2023 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jan 24, 2023 NWOS
NEW APPLICATION ENTERED
Jan 2, 2023 NWAP